Follow GeneConvene
GeneConvene Global Collaborative
Advancing best practices and informed decision making for development of genetic biocontrol technologies to improve public health.
News & Announcements
Skip This Section
Overview
The GeneConvene Global Collaborative is an initiative of the Foundation for the National Institutes of Health that advances best practices and informed decision making for development of genetic biocontrol technologies to improve public health. GeneConvene offers technical information, advice, training, and coordination for research on gene drive and other genetic biocontrol technologies. Building on more than 10 years of work by FNIH on genetic biocontrol approaches for public health, the GeneConvene team is experienced with important technical, regulatory, and policy issues.
|
|
The Gene Drive Research Forum brings together representatives from research, government, private sector, and not-for-profit organizations, as well as other parties with an interest in safe and ethical conduct of gene drive research for applications in public health, conservation, and agriculture. The Forum meets periodically to discuss the status and challenges of gene drive research and identify areas where collaboration, coordination, and cooperation among stakeholders will move the field forward in a positive manner. The Forum also coordinates panels with worldwide experts to discuss current issues related to gene drive.
|
 |
The GeneConvene Virtual Institute (VI) aggregates, curates, and shares knowledge to advance understanding of genetic biocontrol technologies, such as gene drive, as well as selfish genetic elements found throughout nature. The online knowledge hub provides updates on technical progress, policy and regulation, and other news about genetic biocontrol technologies. To support and promote learning and discussion around genetic biocontrol and associated issues, the VI hosts regular educational webinars. |
 |
The Guidance framework for testing genetically modified mosquitoes, developed jointly by the World Health Organization’s Special Programme for Research and Training in Tropical Diseases (WHO-TDR) and the GeneConvene Global Collaborative, describes best practices to ensure that the study and evaluation of genetically modified mosquitoes as public health tools is safe, ethical, and rigorous.
|
 |
The United Nations Convention on Biological Diversity (CBD), signed at the 1992 Rio Earth Summit, is a global agreement to conserve biodiversity, promote sustainable use of environmental resources, and ensure equitable sharing of benefits from the use of genetic resources. A part of the CBD called the Cartagena Protocol on Biosafety specifically protects biological diversity from adverse effects due to use of living modified organisms, which includes organisms containing engineered gene drives. GeneConvene regularly tracks decisions and developments resulting from CBD meetings. |
 |
GeneConvene hosted a Twitter Spaces conversation with Ifakara Health Institute’s Dr. Lina Finda and Dr. Fredros Okumu, moderated by GeneConvene’s Michael Santos. The conversation previewed results from a new study assessing awareness of and attitudes toward gene drive approaches for malaria control among scientists and malaria control professionals across 25 African countries..
|
